Steroid resistant focal segmental glomerulosclerosis: effect of arterial hyalinosis on outcome: single center study

Autor: Amin R. Soliman, Hoda Abdel Hamid Maamoun, Rabab Mahmoud Ahmed, Haytham Soliman
Rok vydání: 2021
Předmět:
Male
Drug Resistance
030232 urology & nephrology
Blood Pressure
030204 cardiovascular system & hematology
urologic and male genital diseases
Single Center
0302 clinical medicine
Focal segmental glomerulosclerosis
Fibrosis
Prospective Studies
Internal medicine
Proteinuria
medicine.diagnostic_test
Glomerulosclerosis
Focal Segmental

steroid
Eye Diseases
Hereditary

Arterioles
Treatment Outcome
Cyclosporine
Prednisolone
Drug Therapy
Combination

Female
Renal biopsy
medicine.symptom
Immunosuppressive Agents
Glomerular Filtration Rate
medicine.drug
Adult
Diarrhea
Hyalin
medicine.medical_specialty
Urology
Renal function
03 medical and health sciences
medicine
Humans
Vascular Diseases
Glucocorticoids
focal segmental glomerulosclerosis
business.industry
Mycophenolic Acid
medicine.disease
RC31-1245
Intestinal Diseases
Blood pressure
Skin Abnormalities
business
Zdroj: Romanian Journal of Internal Medicine, Vol 59, Iss 2, Pp 127-133 (2021)
ISSN: 2501-062X
Popis: Background. Few data with adequate evidence exists as regards the effect of Cyclosporine (CsA) and mycophenolate mofetil (MMF) on pathological prognostic parameters in patients with steroid resistant focal segmental glomerulosclerosis (FSGS). The purpose of the present study is to compare the effect of cyclosporin and mycophenolate mofetil in addition to steroids on functional and histopathologic renal parameters in patients with steroid resistant FSGS one year after treatment. Material and methods. Thirty-seven adults with primary FSGS patients resistant to steroid therapy consecutively randomized to treatment with either MMF or cyclosporine. Low dose prednisolone added to both groups. Glomerular filtration rate (GFR) and blood pressure (BP) were determined at all examinations and a second renal biopsy was taken 12 months after treatment with either of cyclosporin and mycophenolate mofetil. Results. GFR significantly increased in MMF group p < 0.01 after 6 months and unchanged after 12 months. On the other hand, GFR significantly decrease in CsA group p < 0.001 after 6 months and reduced more after 12 months p < 0.001 compared to base line levels. There was a significant difference of GFR between the 2 groups at 6 months p < 0.001. The extent of proteinuria decreased significantly in CsA group after 12 months p < 0.001. The extent of arteriolar hyalinosis increased significantly in CsA group (0.78 to 1.81 score, p < 0.001) but was unchanged in MMF group (0.93 to 0.96 score), whereas interstitial fibrosis increased to same level in both groups (grade 3). Conclusion. Conversion to MMF in those patients may be superior to CsA as regards GFR after 12 months after treatment in spite of the presence of greater level of protein excretion. The increased arteriolar hyalinosis during CsA treatment most likely results in higher BP compared to MMF treatment in patients with FSGS resistant to steroids.
Databáze: OpenAIRE